tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Hartaj Singh, 188 are a BUY (94.47%), 11 are a HOLD (5.53%).
Analyst Hartaj Singh, carries an average stock price target met ratio of 50.39% that have a potential upside of 38.91% achieved within 348 days. Previously, Hartaj Singh worked at OPPENHEIMER, BTIG.
Hartaj Singh’s has documented 369 price targets and ratings displayed on 35 stocks. The coverage was on Healthcare, Industrials, Consumer Defensive sectors.
Most recent stock forecast was given on TRDA, Entrada Therapeutics at 24-Mar-2025.
Analyst best performing recommendations are on ONCT (ONCTERNAL THERAPEUTICS).
The best stock recommendation documented was for MRNA (MODERNA) at 11/16/2020. The price target of $157 was fulfilled within 17 days with a profit of $59.05 (60.29%) receiving and performance score of 35.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
Buy Since 17-Jul-2017
$166
$-16.5 (-9.04%)
$175
What Year was the first public recommendation made by Hartaj Singh?
